FDA's use of guidance documents will be focus of Sept. 14 House hearing.
This article was originally published in The Tan Sheet
Executive Summary
FDA's USE OF GUIDANCE DOCUMENTS WILL BE FOCUS OF SEPT. 14 CONGRESSIONAL HEARING to be held by two subcommittees of the House Government Reform Committee: Rep. Christopher Shays' (R-Conn.) Human Resources Subcommittee and Rep. David McIntosh's (R-Ind.) Regulatory Affairs Subcommittee. The hearing, which will focus on FDA enforcement issues, will examine the extent to which FDA requires compliance with guidance documents that are not promulgated as regulations.